A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia

by Schweighofer, Carmen D., Coombes, Kevin R., Barron, Lynn L., Diao, Lixia, Newman, Rachel J., Ferrajoli, Alessandra, O'Brien, Susan, Wierda, William G., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Keating, Michael J., Abruzzo, Lynne V.
Published 2011